Purpose of Review Age-period-cohort (APC) models simultaneously estimate the effects of age-biological process of aging; time period-secular trends that occur in all ages simultaneously; and birth cohort-variation among those born around the same year or from one generation to the next. APC models inform understanding of cancer etiology, natural history, and disparities. We reviewed findings from recent studies (published 2008-2018) examining age, period, and cohort effects and summarized trends in age-standardized rates and age-specific rates by birth cohort. We also described prevalence of cancer risk factors by time period and birth cohort, including obesity, current smoking, human papilloma virus (HPV), and hepatitis C virus (HCV). Recent Findings Studies (n = 29) used a variety of descriptive analyses and statistical models to document age, period, and cohort trends in cancer-related outcomes. Cohort effects predominated, particularly in breast, bladder, and colorectal cancers, whereas period effects were more variable. No effect of time period was observed in studies of breast, bladder, and oral cavity cancers. Age-specific prevalence of obesity, current smoking, HPV, and HCV also varied by birth cohort, which generally paralleled cancer incidence and mortality rates. Summary We observed strong cohort effects across multiple cancer types and less consistent evidence supporting the effect of time period. Birth cohort effects point to exposures early in life-or accumulated across the life course-that increase risk of cancer. Birth cohort effects also illustrate the importance of reconsidering the timing and duration of well-established risk factors to identify periods of exposure conferring the greatest risk.
Introduction
Cancer registries across the world monitor incidence and mortality rates to assess the distribution of disease, often informing our understanding of cancer etiology, natural history, and disparities. Age-period-cohort (APC) models provide additional and useful insight by documenting change in cancer incidence and mortality over time that may be attributable to age, time period of observation, and birth cohort [1••] . Models simultaneously estimate the effects of age-biological process of aging; time period-secular trends that occur in all ages simultaneously; and birth cohort-variation among those born in or around the same year or from one generation to the next. Epidemiologic studies using APC models have improved our understanding of the burden and etiology of several cancers. For example, birth cohort effects evidenced in lung cancer [2, 3] point to younger age at smoking initiation and longer duration of smoking as important risk factors.
Although linear APC models have been limited by the identification problem (i.e., age, period, and cohort variables may be perfectly collinear), methodologic advanceshave provided several new APC models useful in cancer research, and that extend beyond the conventional, linear approach. We review recent studies estimating the differential contributions of age, period, and cohort to cancer incidence and mortality. We also estimated prevalenceof cancer riskfactors bytime period and birth cohort.
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Methods
We reviewed findings from studies examining age, period, and cohort effects published between 2008 and 2018. For each study, we described cancer type, geographic location, data source, and statistical methods. We also summarized temporal trends in age-standardized rates and age-specific rates by birth cohort.
Prevalence of Cancer Risk Factors
We described trends in the prevalence of cancer risk factors by time period and birth cohort, including obesity, current smoking, human papilloma virus (HPV), and hepatitis C virus (HCV). We obtained prevalence estimates from the National Health and Nutrition Examination Survey (NHANES) from 1999 through 2016 (approximately 45,000 adults age ≥ 18 years). NHANES includes a standardized physical examination, where trained health technicians collect a complete set of anthropometric and laboratory measures from survey participants.
Obesity Body weight and height were measured in mobile examination centers using standardized procedures and equipment. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m 2 ), and then rounded to one decimal place. Consistent with national guidelines, we defined obesity as BMI ≥ 30 kg/m 2 .
Current Smoking We defined current smoking by combining responses to two survey questions: (1) "Have you smoked at least 100 cigarettes in your entire life?" and (2) "Do you now smoke cigarettes?" Interview questions are asked in the home by trained interviewers using the Computer-Assisted Personal Interviewing (CAPI) system. Participants who replied "yes" to the first question and reported now smoking "every day" or "some days" were considered current smokers.
Hepatitis C Virus NHANES participants' serum specimens are tested for antibodies to HCV (anti-HCV) using VITROS Anti-HCV chemiluminescence assay (CIA). Supplemental recombinant immunoblot assays (RIBA) (Chiron RIBA 3.0 Strip Immunoblot Assay) are performed on all repeatedly positive specimens by CIA testing. Specimens with a positive RIBA results are reported as confirmed positive for antibody to HCV. Because the confirmed anti-HCV test was discontinued by the manufacturer in 2012, and subsequently no longer used in NHANES, we estimated prevalence of anti-HCV through 2012 only.
Human Papilloma Virus Women (ages 18-59 years) participating in NHANES provide self-collected vaginal swabs, which are then analyzed for 37 HPV genotypes using the Roche Linear Array Assay. We estimated prevalence of all high-risk HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) , as well as prevalence of genotypes 16 and 18 (targeted in all vaccines).
For each risk factor, we report temporal trends in prevalence, as well as age-specific prevalence by birth cohort, separately for men and women. All prevalence estimates are weighted to account for survey sampling and nonresponse.
Results
Age, Period, and Cohort Effects and Cancer Incidence and Mortality Table 1 summarizes findings from 29 studies of cancer incidence and/or mortality of breast, liver, gastric, bladder, bone, esophageal, oral cavity, lung, colorectal, pancreatic, and prostate cancers and leukemia. Most studies were conducted in the USA, although about one third were conducted internationally, including Canada, Norway, China, Argentina, Mexico, France, Japan, and Spain. A variety of statistical methods were used across studies (Table 2) . Findings relevant to each cancer type are described below.
Breast In studies of breast cancer, we noted variable period and cohort effects across studies by geographic region. For example, age-standardized incidence rates declined from 1980 through to 2010 in the USA [25] but increased in other countries during the same period [26, 27] . Despite these differences, most studies of breast cancer show a stronger cohort effect than period effect, which may be due to estrogen-related or reproductive risk factors (e.g., age at menarche, breastfeeding patterns, number of pregnancies and age at childbirth) [19] .
Liver Worldwide, age-standardized incidence of liver cancer has increased dramatically since the late 1970s [13, 20, 28, 29] , primarily driven by increases in hepatocellular carcinoma. Agespecific incidence has also increased across successive birth cohorts through the 1960 birth cohort [28] and subsequently declined [20] . Chronic HCV infection, a common blood-borne infection, increases risk of liver cancer [30, 31] , and about 75% of adults infected with HCV in the USA are baby boomers (born between 1945 and 1965). Baby boomers likely became infected from contaminated blood and blood products before widespread screening began in the early 1990s [6] .
Colorectal Age-standardized incidence and mortality rates of colorectal cancer have decreased in the USA since the mid-1980s [32] , with particularly dramatic declines among older adults (age ≥ 50 years). In contrast, incidence Lung Two US studies of lung cancer incidence show agespecific incidence and mortality rates declined starting in the 1990s [9, 34] . Incidence and mortality rates have also declined across successive birth cohorts after about the 1930 birth cohort, which parallels dramatic declines in the prevalence of smoking by cohort [10, 12] . However, incidence increased among women born in 1950 to 1960, and in certain age groups, incidence rates in women have surpassed those of men [9] . Because the prevalence of smoking has decreased among women born in the 1950s and 1960s, this increase in [37] . Cohort trends appeared more consistent, and agespecific rates were generally higher among birth cohorts born in the early 1900s [35, 36•] . Smoking causes about half of all bladder cancers [5, 38] , and the consistent declines across birth cohorts may be due to simultaneous declines in smoking prevalence by birth cohort [10, 12] .
Oral Cavity In the USA [39] and economically developed countries [40, 41] , age-standardized incidence rates of HPVrelated oral cancers (e.g., oropharyngeal cancers-tonsils, tonsillar crypt, base of tongue) increased from the early 1980s through to the most recent time period, particularly among men. Age-specific incidence generally increased across successive birth cohorts starting with persons born in 1930. HPV is the most common sexually transmitted infection and the leading cause of oropharyngeal cancers (thought to cause 70% in USA [8, 42] ). Oral HPV is transmitted via oral sex, and changes in sexual behavior [14, 43] in the 1960s may explain rising incidence in more recent birth cohorts.
Gastric Across all racial/ethnic groups in the USA, agestandardized incidence rates of gastric cancer declined starting in the late 1970s [44] . Age-specific incidence rates declined among Whites through about the 1950 birth cohort and then subsequently increased among more recent cohorts. The majority of gastric cancers are attributable to chronic infection with Helicobacter pylori [45] , commonly acquired in childhood. In the USA, prevalence of H. pylori has decreased dramatically across birth cohorts [46] , likely due to improvements in sanitation and increased antibiotic use [47] . Lower gastric cancer incidence rates among older birth cohorts may reflect decreased H. pylori infection in their childhood, but reasons for increasing rates in younger birth cohorts remain unclear. Esophagus Starting in about 1985, age-standardized incidence rates of esophageal adenocarcinoma exceeded rates of squamous cell carcinoma worldwide [48] . Rates of squamous cell carcinoma steadily declined during this same period [49] . In the USA, age-specific incidence rates increased from about 1990 to 2012 and across successive birth cohorts born from 1885 to 1950 [18•] . Increasing rates of esophageal adenocarcinoma have been attributed to increasing prevalence of risk factors, such as obesity [7] and gastroesophageal reflux disease [50, 51] . Our prior work shows a stronger period effect than cohort effect, largely explained by temporal trends in obesity [18•] . Although the increase in esophageal adenocarcinoma has slowed in recent years, it remains one of the few cancers in the USA with a rising incidence [52] .
Pancreas Age-standardized mortality rates of pancreatic cancer in the USA have varied by race/ethnicity and sex [53] . For example, among White men, rates decreased from 1970 to 1995 but increased among White women during the same period. Rates also increased among Black men and women from 1970 to 1989, and then subsequently declined through to 2009. Cohort effects appeared stronger in men than women, and age-specific mortality rates decreased among White and Black men after the birth cohort born in 1910. Racial differences in the prevalence of risk factors, such as smoking, diabetes, and obesity [54, 55] , which also differ by sex, may contribute to these observed trends.
Leukemia Because leukemia comprises a heterogeneous group of cancers, period and cohort trends differ according to subtype. Age-standardized incidence rates of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) decreased from 1992 to 2009 [56] . However, rates of acute lymphoblastic leukemia (ALL), most common among children and older adults, increased during the same period.
Age-specific incidence rates of ALL have also increased across successive birth cohorts, starting with persons born in the mid-1940s.
Bone Similarly, bone cancer comprises a diverse group of cancers, including osteosarcoma, Ewing sarcoma, and chondrosarcoma. Age-standardized incidence rates of bone cancer have been generally stable since the late 1970s [57] . Notably, age-specific incidence rates of osteosarcoma declined in successive birth cohorts born between 1905 and 1934.
In studies of common cancer types (Table 3) , period and cohort effects were assessed descriptively and in statistical models. Most studies described trends in one dimension (e.g., period changes in rates for all ages combined) or two dimensions (e.g., cohort changes in age-specific rates). Fewer studies reported results of statistical models estimating the independent effects of age, period, and cohort. In these studies, cohort effects predominated, particularly in breast, bladder, and colorectal cancers, whereas period effects were more variable. No effect of time period was observed in studies of breast, bladder, and oral cavity cancers.
Prevalence of Cancer Risk Factors by Period and Cohort
Obesity Prevalence of obesity (BMI ≥ 30 kg/m 2 ) increased from 1999 to 2016, and prevalence was higher among women than men in all survey years (Fig. 1) . Among men, prevalence ranged from 27 to 32%, and among women, from 32 to 39%. Age-specific prevalence across birth cohorts also differed by sex. Except for the youngest age group (18-29 years), obesity increased among men in all age groups and across successive birth cohorts, with particularly steep increases from the 1930 though 1955 birth cohorts. Cancer types for which we identified only one study in our review are not included in the table + reported association in at least one study; ++ reported association in two or more studies; *null findings in at least one study Prevalence was highest among men age 60-69 years. In contrast, age-specific prevalence of obesity generally declined across successive birth cohorts among women. Obesity increased slightly among women born in 1915 through 1935, and subsequently remained stable or decreased.
Current Smoking As shown in Fig. 2 , prevalence of smoking declined slowly from 1999 through 2016 and remained consistently higher among men (range 21-29%) than women (range 16-22%). Age-specific prevalence of smoking was highest among 18-29-year-old men born in the 1970s. Prevalence remained stable in all age groups for birth cohorts born from 1915 to 1940 but then decreased across successive birth cohorts. Among women, starting with the 1955 birth cohort, there were sharp declines in smoking in all age groups through the 1995 birth cohort.
Hepatitis C Virus After an increase in prevalence from 1999 to 2002, anti-HCV remained stable through 2012 (Fig. 3) . Prevalence was consistently higher among men than women, and in both groups remained low, around 2%. Cohort trends in anti-HCV appeared much more prominent. In men and women, there were sharp increases in age-specific prevalence across the 1945 to 1960 birth cohorts. 
Conclusion
APC methods identify and quantify variation in cancer incidence and mortality associated with age, time period, and birth cohort. Across 29 studies of multiple cancer types, we observed stronger birth cohort effects than period effects. Birth cohort effects point to exposures early in life-or accumulated across the life course-that increase risk of cancer. Birth cohort effects also illustrate the importance of reconsidering the timing and duration of well-established risk factors to identify periods of exposure conferring the greatest risk. For example, obesity, associated with increased risk of several cancers [58] , may contribute to some of the observed increases in incidence.
Measuring obesity during windows of growth and development (e.g., birthweight [59] or childhood obesity [60] ) may advance our understanding of its role in carcinogenesis and identify vulnerable periods of exposure that matter most. We found less consistent evidence supporting the effect of time period, which also differed by geographic region (i.e., temporal trends were not consistent across the globe). These regional differences may point to the influence of screening or diagnostic practices, such as mammography screening. Indeed, studies of breast cancer incidence and mortality showed the greatest variations in period effects, and in some regions, there was no period effect.
Economically developed countries have adopted screening mammography guidelines at various time points (e.g., early 1980s in the USA [61] , early 1990s in the UK [62, 63] ), and the USA was among the early adopters. This may explain why mortality rates declined in earlier time periods in the USA but not in other regions. Differences in period effects or temporal trends across geographic region may also underscore differences in the timing of risk factor prevalence. For example, HCV became prevalent in Asian countries before it did in the USA, which parallels trends in liver cancer incidence between the two regions.
Trends in cancer incidence and mortality generally paralleled prevalence of risk factors. For example, prevalence of anti-HCV was highest among birth cohorts born between 1945 and 1960, and incidence rates of liver cancer were highest among these cohorts [20, 28, 29] . Declines in the prevalence of smoking by birth cohort also mirrored agespecific rates of lung [9, 34, 41] , bladder [35] [36] [37] , and pancreatic [53] cancer incidence and mortality. Although there were some exceptions, rates of these cancers often declined in birth cohorts with lower prevalence of smoking. Meanwhile, prevalence of obesity has increased by time period and birth cohort, which may contribute to recent observations that the incidence of gastric [44] and colorectal [32] cancer has increased among younger adults.
Studies used a variety of descriptive analyses and statistical models to track age, period, and cohort effects. Nearly all included one-dimensional or summary indices to describe period variation in overall incidence or mortality rates. Although useful for understanding cancer burden, these indices may be less relevant to APC analysis because they (1) only describe variation in rates attributable to factors during the period of cancer diagnosis or death, ignoring different trends at different ages; and (2) are sensitive to the choice of standard population (i.e., for age-standardizing), which may not capture recent changes in population structure due to aging. Other studies used two-dimensional graphical displays, which improve upon summary indices by providing information on age-specific change. For example, many studies described or displayed age-specific trends across birth cohorts. Two-dimensional trends are helpful for qualitative impressions about patterns for each age group but not for quantitative assessment of the source of change.
Fewer studies reported results of statistical models, and of those that did, most used linear models and an estimable function approach. Estimable functions, such as deviation, curvature, and drift, are used to derive estimates [4, 21, 23, 64] . For example, many ascribe net drift (annual percent change of the expected age-standardized rates) to overall log-linear trends by time period and birth cohort. These approaches generally use constraints to resolve the identification problem inevitable in linear models, raising two important limitations. First, different constraints yield different estimates but identical or similar model fit. Second, effect estimates are sensitive to the choice of the identifying constraints and require a priori information, which rarely exists. These limitations also make it challenging to compare findings across studies. While we recommend researchers present results of linear models in conjunction with a detailed descriptive analysis [1] and use caution in interpretation of these results, we also suggest using hierarchical APC models. Hierarchical models not only address the problems inherent in linear models, but they also offer the additional advantage of including covariates or risk factors to test explanatory hypothesis about the underlying mechanisms for observed age, period, and cohort trends.
In summary, APC models track changes in cancer incidence and mortality over time that may be attributable to age, time period of observation, and birth cohort. We observed strong cohort effects across 29 studies of various cancer types, highlighting the importance of early life exposures that may promote biological pathways initiating carcinogenesis in adulthood. We also observed variations in cancer risk factors (e.g., obesity, smoking) by time period and birth cohort, which paralleled trends in cancer incidence and mortality.
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